Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Eir
  6. /
  7. Alcami Carolinas Corporation
EIR
•Alcami Carolinas Corporation•January 29, 2019

Alcami Carolinas Corporation – FDA EIR, Jan 29, 2019

Record Details

An FDA inspection of Alcami Corporation, a contract manufacturer of solid oral dosage drugs and control testing facility located in Wilmington, North Carolina, took place from January 23 to January 29, 2019. The inspection assessed the firm's adherence to current Good Manufacturing Practices (cGMP), aligning with Compliance Program 7356.002, Drug Manufacturing Inspections, which falls under the Food Drug and Cosmetic Act's adulteration provisions. While the inspection concluded without the issuance of a Form FDA 483 (Inspectional Observations), certain systemic gaps were discussed with management. These included incomplete cleaning validation for a tablet press, as the feed frame was initially omitted from swabbing and testing. Concerns also arose regarding cleaning swab procedures being conducted without a fully validated recovery method for specific equipment. Furthermore, a lack of comprehensive user access lists for certain manufacturing equipment, particularly a tablet press, was identified. Alcami's management acknowledged these findings, stating that the firm had already begun assessing these areas. The company committed to implementing ongoing corrections and continuous improvements to resolve the identified issues, demonstrating a cooperative approach to addressing the FDA's observations.

Company
Alcami Carolinas Corporation
Inspection date
January 29, 2019
Product type
drugs
Office
Atlanta District Office
People
  • Mark Lewis (company_representative)
  • Scott Jedrey (company_representative)
  • Gwendalynn Ritchie (company_representative)
  • Matt Ressner (company_representative)
  • Mike Reel (company_representative)
View Company Profile

ID · a3003494-5d87-47c0-9dc1-be116b98165d

Violation Codes1
FD&C Act 501(a)(2)(B)

Full citation text and observation details available on the Dashboard.

Other documents for Alcami Carolinas Corporation
  • 483 - 2025-09-26September 26, 2025
  • EIR - 2025-09-26September 26, 2025
  • 483 - 2025-01-31January 31, 2025
  • EIR - 2021-02-18February 18, 2021
  • EIR - 2019-08-09August 9, 2019

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Alcami Carolinas Corporation
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.